These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6144879)

  • 1. Prophylaxis: a strategy to minimise antiviral resistance.
    Ambinder RF; Burns WH; Lietman PS; Saral R
    Lancet; 1984 May; 1(8387):1154-5. PubMed ID: 6144879
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance of herpes simplex virus to antiviral agents. Is it clinically important?
    Crumpacker C
    Drugs; 1983 Nov; 26(5):373-7. PubMed ID: 6315331
    [No Abstract]   [Full Text] [Related]  

  • 3. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
    de Clercq E
    Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
    [No Abstract]   [Full Text] [Related]  

  • 4. Virus drug-resistance: mechanisms and consequences.
    Larder BA; Darby G
    Antiviral Res; 1984 Apr; 4(1-2):1-42. PubMed ID: 6331303
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.
    Levin MJ; Weinberg A; Leary JJ; Sarisky RT
    Pediatr Infect Dis J; 2001 Nov; 20(11):1094-7. PubMed ID: 11734722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies of drug resistance in herpes simplex.
    Field HJ; Darby GK
    Nature; 1980 Aug; 286(5776):842. PubMed ID: 6251373
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
    Field HJ; Neden J
    Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
    Safrin S
    Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.
    Safrin S; Phan L
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2241-3. PubMed ID: 8257152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
    Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
    Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired resistance to acyclovir: laboratory phenomenon or clinical problem?
    Field HJ
    J Infect; 1983 May; 6(1 Suppl):11-4. PubMed ID: 6309981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiviral resistance of herpes simplex virus and varicella-zoster virus].
    Daikoku T; Shiraki K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():480-6. PubMed ID: 17455667
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus.
    Swetter SM; Hill EL; Kern ER; Koelle DM; Posavad CM; Lawrence W; Safrin S
    J Infect Dis; 1998 Mar; 177(3):543-50. PubMed ID: 9498430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
    Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
    J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation by thymidine kinase and potent antiherpetic activity of 2'-nor-2'-deoxyguanosine (2'NDG).
    Ashton WT; Karkas JD; Field AK; Tolman RL
    Biochem Biophys Res Commun; 1982 Oct; 108(4):1716-21. PubMed ID: 6295389
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance and latency.
    Field HJ
    Br Med Bull; 1985 Oct; 41(4):345-50. PubMed ID: 2996685
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
    Field HJ; Larder BA; Darby G
    Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
    Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
    Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.